Renal Cell Carcinoma with Clear Cell Papillary Features Perspectives of a Differential Diagnosis /

Somorácz Áron, Kuthi Levente, Micsik Tamás, Jenei Alex, Hajdú Adrienn, Vrabély Brigitta, Rásó Erzsébet, Sápi Zoltán, Bajory Zoltán, Kulka Janina, Iványi Béla
2020

Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC) an open-label, non-randomized, multi...

Markóczy Zsolt, Sárosi Veronika, Kudaba Iveta, Gálffy Gabriella, Turay Ülkü Yilmaz, Demirkazik Ahmet, Purkalne Gunta, Somfay Attila, Pápai-Székely Zsolt, Rásó Erzsébet, Ostoros Gyula
2018